Peuchmaur M, Benoit G, Vieillefond A, Chevalier A, Lemaigre G, Martin E D, Jardin A
Department of Pathology, Antoine Béclère Hospital, Clamart, France.
Urol Res. 1989;17(5):299-303. doi: 10.1007/BF00262987.
Immunohistochemical techniques were used to investigate leucocyte subpopulations in the bladders of patients with superficial transitional cell carcinoma treated with BCG Pasteur. Leucocyte subsets were enumerated with a panel of monoclonal antibodies which included CD3, CD4, CD8, TQ1, Leu7, CD15, HLA-DR, CD25, CD22. We demonstrated in the bladders of patients treated with BCG a particular lymphocyte population; the major subset was an inducer (CD4+, TQ1-) which was activated (CD25+, HLA-DR+) and associated with polymorphonuclear eosinophils. There was neither inducer of suppression nor major cytotoxic/suppressive subsets. CD8+ and NK cells could not be the primary mediators of BCG activity. These data supported the hypothesis of a helper T lymphocyte activity associated with lymphokine production and activation of effector killer cells.
采用免疫组织化学技术研究了用巴斯德卡介苗治疗的浅表性移行细胞癌患者膀胱中的白细胞亚群。用一组单克隆抗体对白细胞亚群进行计数,这些抗体包括CD3、CD4、CD8、TQ1、Leu7、CD15、HLA-DR、CD25、CD22。我们在接受卡介苗治疗的患者膀胱中证实了一种特殊的淋巴细胞群体;主要亚群是诱导型(CD4 +、TQ1 -),其处于激活状态(CD25 +、HLA-DR +)并与多形核嗜酸性粒细胞相关。既没有抑制诱导型细胞,也没有主要的细胞毒性/抑制亚群。CD8 +细胞和自然杀伤细胞不可能是卡介苗活性的主要介质。这些数据支持了与淋巴因子产生和效应杀伤细胞激活相关的辅助性T淋巴细胞活性的假说。